Presentation is loading. Please wait.

Presentation is loading. Please wait.

Miss Kathryn Hillaby MD MRCOG Consultant Gynaecological Oncologist, Colposcopy Lead for Gloucestershire.

Similar presentations


Presentation on theme: "Miss Kathryn Hillaby MD MRCOG Consultant Gynaecological Oncologist, Colposcopy Lead for Gloucestershire."— Presentation transcript:

1 Miss Kathryn Hillaby MD MRCOG Consultant Gynaecological Oncologist, Colposcopy Lead for Gloucestershire

2 Cervical Carcinoma – where are we now? Total cases in England in 2008 = 2,369 Mortality = 753 women in yr relative survival rate = 86% 5 yr relative survival rate = 68%

3 Cervical carcinoma Peak incidence Incidence rates have halved in UK in last 20 yrs Linked to HPV and smoking

4 Cervical carcinoma Number of cases highest in those aged 25-49, these women represent over half of all diagnoses Rates peak in women in early 30’s, gradually reduce in 40’s and rise again in women in 70’s and early 80’s Both incidence and mortality worse in deprived areas Cervical cancer is worse in older women – 1 yr survival in those aged is 96% compared with 52% in those aged 80 or older

5 Cervical Carcinoma

6 Cervical carcinoma Incidence and mortality rates have fallen considerably over past 20 yrs Incidence rates have almost halved (16.2 to 8.3 per 100,000 female population) Mortality rates reduced by 2/3 (from 6.4 to 2.2 per 100,000 female population) Incidence fell sharply following introduction of Cervical screening programme

7 Cervical carcinoma HOWEVER: Reduction in incidence has levelled off in recent years Between 1998 and 2008 incidence in women aged increased by 77%

8 Worldwide Cervical carcinoma 12 th most common cancer in women, and 5 th most deadly In young women is 2 nd most common carcinoma 80% occurs in developing countries Kills 250,000 women per year

9 Map of incidence by Cancer Network,

10 Map of mortality by Cancer Network,

11 Cervical carcinoma

12 Colposcopy – apply acetic acid to cervix Biospy or LLETZ - Squamous cell carcinoma (85%) Adenocarcinoma (15%)

13 Colposcopy

14 Cervical carcinoma staging Staging is clinical FIGO staging Based on EUA, cystoscopy +/- sigmoidoscopy Does NOT include MRI In UK investigations include MRI pelvis and CT chest/abdo/pelvis

15 Cervical carcinoma Investigations – CT and MRI EUA and cystoscopy

16 Stage 1 disease Stage 1A Stage 1A1 = <3mm depth of invasion and <7mm wide Stage 1A2 = 3-5mm depth of invasion and <7mm wide Treatment = LLETZ

17 Stage 1 disease Stage 1B = any tumour which is visible Stage 1B1 = <4cm Stage 1B2 = >4cm Confined to cervix Treatment = surgical for 1B1 Chemo Radiotherapy for 1B2

18 Stage 2 disease Stage 2 = invades beyond uterus, but not to pelvic sidewall or lower 1/3 of vagina Stage 2A – spread into the top of the vagina 2A1 = <4cm 2A2 = >4cm

19 Stage 2 disease Stage 2B – spread into parametrium

20 Stage 3 disease Tumour extends to pelvic sidewall and/or involves lower 1/3 of vagina and/or causes hydronephrosis Stage 3A – Cancer has spread to lower 1/3 of vagina, but not to pelvic sidewall

21 Stage 3 disease Stage 3B disease Spread to pelvic sidewall and / or hydronephrosis

22 Stage 4 Carcinoma has extended beyond true pelvis or has involved mucosa of bladder or rectum Stage 4a – spread of growth to adjacent organ

23 Stage 4 disease Stage 4B – spread to distant organs

24 Staging and treatment Surgical in women up to stage 1b1 Chemotherapy (cisplatin) with radiotherapy in women with disease > stage 1b1

25

26

27

28 Cervical carcinoma 36 cases Stage 1B1 and above per year Gloucestershire, Herefordshire and S Worcestershire Stage 1b1 or less managed surgically Stage 1b2 and above managed with chemo- radiotherapy Survival rates >85% in women <40yrs

29 How can we tackle this? Reduce incidence by screening Treatment – of CIN to stop progression to cervical cancer Early detection of cervical carcinoma Adequate treatment

30 Cervical screening programme Cervical screening programme saves 4500 lives per year in UK Cervical screening prevents up to 3,900 cases of cervical cancer per year in the UK

31 Cervical screening programme Early detection can prevent 75% cervical cancers Currently between 77-83% women attend for screening 2007/ % women 25-34yrs did not attend for smears

32 What happened? statistics show that the number of women of all ages having cervical screening has increased to 3.7 million compared with 3.4 million last year, an increase of 10.5 per cent (around 353,000). Those within the 25 to 64 age range have risen to 3.6 million from 3.2 million last year, an 11.9 per cent increase (around 384,000). The majority of this increase is for women aged 25 to 49. It is thought to be due to the publicity surrounding the illness and death of Jade Goody.

33 Take home messages Cervical screening programme works Prevents 70% cases cervical carcinoma Saves 4500 women per year Only works if women attend for smear HPV vaccine prevents 70% cases cervical cancer Uptake currently disappointing


Download ppt "Miss Kathryn Hillaby MD MRCOG Consultant Gynaecological Oncologist, Colposcopy Lead for Gloucestershire."

Similar presentations


Ads by Google